The signaling protein AKT is involved in the regulation of cell proliferation and apoptosis, is activated downstream of β-ARs in pancreatic cancer cells in a cAMP-dependent manner, and AKT inhibitors are being used in combination with cancer therapeutics to improve clinical outcomes in pancreatic cancer patients. The gene discussed is AKT1; the disease is pancreatic neoplasm.